Levels of antibodies to SARS-CoV-2 at key time points during the COVID-19 pandemic in China

Front Public Health. 2023 Nov 22:11:1271917. doi: 10.3389/fpubh.2023.1271917. eCollection 2023.

Authors

Liu Lina¹, Liu Hui¹

Affiliation

¹ Department of Laboratory and Quarantine, Dalian Medical University, Dalian, China.

No abstract available

Keywords: COVID-19; SARS-CoV-2; antibody; public health; vaccination.

MeSH terms

COVID-19* / epidemiology
China / epidemiology
Humans
Pandemics
SARS-CoV-2*

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.